KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) Other Non Operating Income (2021 - 2025)

Biolife Solutions (BLFS) has disclosed Other Non Operating Income for 5 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 59200.0% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 267.61% year-over-year, with the annual reading at $1.8 million for FY2025, 267.41% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $1.2 million at Biolife Solutions, up from $284000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.2 million in Q4 2025, with the low at -$22000.0 in Q2 2022.
  • Average Other Non Operating Income over 5 years is $251555.6, with a median of $241000.0 recorded in 2023.
  • The sharpest move saw Other Non Operating Income plummeted 100.73% in 2024, then surged 59200.0% in 2025.
  • Over 5 years, Other Non Operating Income stood at $296000.0 in 2021, then soared by 32.43% to $392000.0 in 2022, then plummeted by 30.36% to $273000.0 in 2023, then tumbled by 100.73% to -$2000.0 in 2024, then soared by 59200.0% to $1.2 million in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $1.2 million, $284000.0, and $247000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.